CCL2 and myeloid sarcoma: These findings could appear incoherent with the anti-inflammatory activity of 1,25(OH)2D3 as a pathogenic role of CCL2/CCR2, as well as of CCR5 and its ligands, which in MS is widely recognized [54,55].